Clinical Trial Update: Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing recombinant streptokinase with urokinase for pulmonary embolism in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Recombinant streptokinase (streptokinase (recombinant))
• Urokinase (urokinase)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Pulmonary Embolism, Pulmonary Thromboembolism | Phase 4 | Status: COMPLETED